5 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
HIV-AIDS Oropharyngeal ... #candida #mucosal ... #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
HHV-8 Diseases—Kaposi ... (MCD) in HIV-AIDS ... and uncontrolled HIV ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
for Treating Cytomegalovirus ... Infections in HIV-AIDS ... #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
for Treating Mycobacterium ... HIV-AIDS Treating ... suggestive of HIV-related ... for HIV-related ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Avium Complex in HIV-AIDS ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology